Section 1115 waiver

Section 1115 waiver
Name	Section 1115 waiver
Type	Medicaid demonstration authority
Started	1965
Legal basis	Social Security Act
Administered by	Centers for Medicare & Medicaid Services
Related	Medicaid, Medicare, Affordable Care Act

Contents

Section 1115 waiver

The term denotes a statutory demonstration mechanism authorizing experimental Medicaid and Children's Health Insurance Program policies through state-specific demonstrations overseen by the Centers for Medicare & Medicaid Services, enabling departures from federal applicable Social Security Act provisions to test delivery, coverage, and financing innovations. Early demonstrations influenced nationwide Medicaid expansion debates and intersect with landmark developments such as the Affordable Care Act, the Tax Cuts and Jobs Act of 2017, and key litigation including King v. Burwell and National Federation of Independent Business v. Sebelius. States such as California, Texas, Florida, New York, and Arizona have pursued varied demonstrations impacting enrollment, benefits, and provider payment methodologies.

Overview

Section 1115 waivers arise from a provision enacted in the Social Security Amendments of 1965 to permit experimental projects within Medicaid and CHIP frameworks under federal supervision by the Department of Health and Human Services and the Centers for Medicare & Medicaid Services. Historically notable demonstrations include initiatives in Tennessee, Oregon, and Massachusetts that informed debates during the passage of the Affordable Care Act and subsequent state strategies in 2010 United States elections, 2012 United States presidential election, and policy shifts under administrations of Barack Obama, Donald Trump, and Joe Biden. Demonstrations often link to state fiscal management efforts seen in balanced budget contexts and interact with federal rulings from the Supreme Court of the United States.

The enabling statute folded into the Social Security Act authorizes experimental projects intended to promote the objectives of Medicaid and CHIP while granting flexibility to test approaches for improving access, quality, and cost-effectiveness. Legal contours connect to opinions from the United States Court of Appeals for the District of Columbia Circuit, guidance from the Office of Management and Budget, and administrative rulemaking overseen by the Department of Health and Human Services. Purpose statements frequently cite aims similar to those articulated in federal initiatives like Medicare Shared Savings Program, Blueprint for Reform, and Children's Health Insurance Reauthorization Act of 2009 while remaining constrained by statutory floor and ceiling considerations adjudicated in cases such as King v. Burwell.

States submit demonstration proposals through a negotiation process with the Centers for Medicare & Medicaid Services involving concept papers, operational protocols, and budgetary estimates; prominent applicants include California Department of Health Care Services, Texas Health and Human Services, and New York State Department of Health. Approvals reference scoring and evaluation frameworks similar to federal grant reviews used by agencies like the Agency for Healthcare Research and Quality and involve public notice and comment procedures akin to those in Administrative Procedure Act practice. Major milestones include federal review, negotiation, conditional approval letters, and implementation timelines, with oversight tied to reporting obligations comparable to Government Accountability Office audits and scrutiny by legislative committees such as the United States Senate Committee on Finance and the United States House Committee on Ways and Means.

States pursue a spectrum of provisions in demonstrations: coverage expansion and eligibility pathways modeled after the Affordable Care Act marketplaces; delivery system reforms like managed care contracts and value-based payment arrangements exemplified in Accountable Care Organizations; benefits redesigns including behavioral health integration influenced by frameworks like Mental Health Parity and Addiction Equity Act; and cost-sharing structures paralleling proposals considered in Health Savings Accounts debates. Specific features often mirror initiatives from jurisdictions such as Oregon Health Plan, Massachusetts Health Care Reform, and Arizona Health Care Cost Containment System, and may incorporate work reporting components echoing proposals in welfare reform discussions and legislation like the Personal Responsibility and Work Opportunity Reconciliation Act of 1996.

Implementation requires state operational systems, contractor arrangements with entities such as Centene Corporation, Kaiser Permanente, and Blue Cross Blue Shield plans, and data systems interoperable with federal reporting requirements including Medicaid Statistical Information System. Oversight relies on monitoring by Centers for Medicare & Medicaid Services, performance metrics comparable to those used in the Medicare Payment Advisory Commission reports, and independent evaluations conducted by academic partners at institutions like Harvard University, Johns Hopkins University, and University of California, Berkeley. Evaluations inform renewal decisions and contribute evidence synthesized by analysts from Kaiser Family Foundation, Brookings Institution, and the Urban Institute.

Demonstrations have spurred debates involving state policymaking in California, Florida, Ohio, and Wisconsin and sparked legal challenges invoking administrative law principles adjudicated by courts such as the United States Court of Appeals for the Fifth Circuit and the United States District Court for the District of Columbia. Critics point to concerns raised by advocacy groups including American Civil Liberties Union, Children's Defense Fund, and Families USA about access, equity, and federal statutory compliance, while supporters cite fiscal control objectives championed by think tanks like the Cato Institute and Heritage Foundation. High-profile controversies include disputes over Medicaid expansion opt-ins seen in 2012 Supreme Court decision on Medicaid expansion contexts, programmatic scope clashes with Affordable Care Act implementation, and administrative discretion tensions highlighted during transitions across presidential administrations.